Data Obtained by Univariate Survival Analysis
Characteristics . | No. . | Deaths Due to ALCL . | 5-yr Survival3-150 (%) . | P Values3-151 . |
---|---|---|---|---|
% GrB+ cells | ||||
<15 | 21 | 3 | 90 | .0006 |
≥15 | 21 | 13 | 37 | |
ALK status | ||||
Negative | 29 | 16 | 45 | .001 |
Positive | 13 | 0 | 100 | |
IPI | ||||
Low | 22 | 3 | 85 | <.0001 |
Low-intermediate | 9 | 4 | 65 | |
High-intermediate | 5 | 5 | 0 | |
High | 6 | 4 | 35 | |
B symptoms | ||||
No | 21 | 5 | 75 | .03 |
Yes | 21 | 11 | 50 | |
Age | ||||
≤60 years | 31 | 10 | 70 | NS |
>60 years | 11 | 6 | 40 | |
Stage | ||||
I | 9 | 2 | 75 | NS |
II | 12 | 2 | 80 | |
III | 9 | 6 | 45 | |
IV | 12 | 6 | 50 | |
Extranodal sites | ||||
0-1 | 32 | 11 | 65 | NS |
>1 | 10 | 5 | 50 | |
LDH level | ||||
≤1 × normal | 27 | 6 | 75 | .004 |
>1 × normal | 14 | 9 | 40 | |
Performance status | ||||
0-1 | 29 | 7 | 75 | .0002 |
2-4 | 13 | 9 | 25 |
Characteristics . | No. . | Deaths Due to ALCL . | 5-yr Survival3-150 (%) . | P Values3-151 . |
---|---|---|---|---|
% GrB+ cells | ||||
<15 | 21 | 3 | 90 | .0006 |
≥15 | 21 | 13 | 37 | |
ALK status | ||||
Negative | 29 | 16 | 45 | .001 |
Positive | 13 | 0 | 100 | |
IPI | ||||
Low | 22 | 3 | 85 | <.0001 |
Low-intermediate | 9 | 4 | 65 | |
High-intermediate | 5 | 5 | 0 | |
High | 6 | 4 | 35 | |
B symptoms | ||||
No | 21 | 5 | 75 | .03 |
Yes | 21 | 11 | 50 | |
Age | ||||
≤60 years | 31 | 10 | 70 | NS |
>60 years | 11 | 6 | 40 | |
Stage | ||||
I | 9 | 2 | 75 | NS |
II | 12 | 2 | 80 | |
III | 9 | 6 | 45 | |
IV | 12 | 6 | 50 | |
Extranodal sites | ||||
0-1 | 32 | 11 | 65 | NS |
>1 | 10 | 5 | 50 | |
LDH level | ||||
≤1 × normal | 27 | 6 | 75 | .004 |
>1 × normal | 14 | 9 | 40 | |
Performance status | ||||
0-1 | 29 | 7 | 75 | .0002 |
2-4 | 13 | 9 | 25 |